What is NDC 87063-288?

87063-288 is the product NDC for naratriptan, Naratriptan hydrochloride 2.5 mg/1 tablet, listed with the FDA by ASCLEMED USA INC.. It has 5 package NDCs, shown above in 10- and 11-digit form.

ASCLEMED USA INC., NDC labeler code 87063. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for naratriptan?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

naratriptan NDC 87063-288 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)87063-288Labeler and product segments. Claims need a package NDC.

Product NDC at billing width87063-0288Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
87063-288-09	8706302880987063028809	9 TABLET in 1 BLISTER PACK (87063-288-09)Marketed from Aug 7, 2026
87063-288-12	8706302881287063028812	12 TABLET in 1 BOTTLE (87063-288-12)Marketed from Aug 7, 2026
87063-288-30	8706302883087063028830	30 TABLET in 1 BOTTLE (87063-288-30)Marketed from Aug 7, 2026
87063-288-60	8706302886087063028860	60 TABLET in 1 BOTTLE (87063-288-60)Marketed from Aug 7, 2026
87063-288-90	8706302889087063028890	90 TABLET in 1 BOTTLE (87063-288-90)Marketed from Aug 7, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): naratriptan
Generic name (nonproprietary): naratriptan
Active ingredients: Naratriptan hydrochloride — 2.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: ASCLEMED USA INC.NDC labeler code 87063
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200502
Marketing start: Mar 15, 2011
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 87063-288_586e484f-099e-4e71-e063-6294a90af7d1SPL ID 586e484f-099e-4e71-e063-6294a90af7d1SPL set ID 63ea356f-0895-4540-b242-8e611eacd938RxCUI 311918, 314135UNII 10X8X4P12Z
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N487063028809 followed by a unit qualifier and the quantity

Package 87063-0288-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 7, 2026.

Indications (excerpt from the label)

Naratriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with naratriptan tablets reconsider the diagnosis of migraine before naratriptan tablets are administered to treat any subsequent attacks. Naratriptan tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of naratriptan tablets have not been established for cluster headache. Naratriptan Tablets are serotonin (5-HT 1B/1D ) receptor agonists (triptan) indicated for the acute treatment of migraine with or witho…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 87063-288

What is NDC 87063-288?: 87063-288 is the product NDC for naratriptan, Naratriptan hydrochloride 2.5 mg/1 tablet, listed with the FDA by ASCLEMED USA INC.. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: naratriptan.
What is the active ingredient?: Naratriptan hydrochloride.
Who is the labeler?: ASCLEMED USA INC., NDC labeler code 87063. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for naratriptan?: 7 other product NDCs are listed under this name. See all naratriptan NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other naratriptan NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Naratriptan	Naratriptan hydrochloride 1 mg/1	Tablet, Film coatedOral	Bionpharma Inc.	69452-340	69452-0340-72
Naratriptan	Naratriptan hydrochloride 2.5 mg/1	Tablet, Film coatedOral	Bionpharma Inc.	69452-341	69452-0341-72
naratriptan	Naratriptan hydrochloride 1 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-054	23155-0054-0323155-0054-0523155-0054-19
naratriptan	Naratriptan hydrochloride 2.5 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-055	23155-0055-0323155-0055-0523155-0055-19
naratriptan	Naratriptan hydrochloride 1 mg/1	TabletOral	ASCLEMED USA INC.	87063-287	87063-0287-0987063-0287-1287063-0287-30+2 more
Naratriptan	Naratriptan hydrochloride 1 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0278	00054-0278-03
Naratriptan	Naratriptan hydrochloride 2.5 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0279	00054-0279-03

Other NDCs under ANDA 200502

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200502
Product	Strength	Form · route	Labeler	Product NDC
naratriptan	Naratriptan hydrochloride 1 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-054
naratriptan	Naratriptan hydrochloride 2.5 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-055
naratriptan	Naratriptan hydrochloride 1 mg/1	TabletOral	ASCLEMED USA INC.	87063-287